The In Vivo Differentiation of Strains of Yellow Fever Virus in Mice

References

1. Billingham R. E., Brent L. 1957; A simple method for inducing tolerance of skin homografts in mice. Transplantation Bulletin 4:67–71
   [Google Scholar]
2. Billingham R. E., Brent L. 1959; Quantitative studies on tissue transplantation immunity. Philosophical Transactions of the Royal Society B242:439–477
   [Google Scholar]
3. Bradish C. J., Farley J. O., Ferrier H. E. 1962; Studies on the nature of the neutralisation reaction and the competition for neutralising antibody between components of the virus system of foot-and-mouth disease. Virology 18:378
   [Google Scholar]
4. Bradish C. J., Allner K., Maber H. B. 1971; The virulence of original and derived strains of Semliki Forest virus for mice, guinea-pigs and rabbits. Journal of General Virology 12:141–160
   [Google Scholar]
5. Bradish C. J., Allner K., Fitzgeorge R. 1975; Immunomodification and the expression of virulence in mice by defined strains of Semliki Forest virus: the effects of cyclophosphamide. Journal of General Virology 28:222–237
   [Google Scholar]
6. Bradish C. J., Fitzgeorge R., Titmuss D., Baskerville A. 1979; Responses of nude-athymic mice to nominally avirulent togavirus infections. Journal of General Virology 42:555–566
   [Google Scholar]
7. Clarke D. 1960; Antigenic analysis of certain group B arthropod-borne viruses by antibody absorption. Journal of Experimental Medicine m:21–32
   [Google Scholar]
8. Darlington R., Granoff A. 1973; Replication - biological aspects. In The Herpesviruses pp 93–132 Edited by Kaplan A. S. New York: Academic Press;
   [Google Scholar]
9. Darnell M., Koprowski H., Lagerspetz K. 1974; Genetically determined resistance to infection with group B arboviruses: I. Distribution of the resistance gene among various mouse populations and characteristics of gene expression in vivo. Journal of Infectious Diseases 129:240–247
   [Google Scholar]
10. Fitzgeorge R., Bradish C. J. 1973; Immunospecific isolation of antibodies by dissociation from virus or particulate antigen adsorbed on charcoal. Immunochemistry 10:21–29
    [Google Scholar]
11. Fitzgeorge R., Bradish C. J. 1980; The differentiation of strains of yellow fever virus in y-irradiated mice. Journal of General Virology
    [Google Scholar]
12. Freestone D. S., Ferris R. D., Weinberg A. L., Kelly A. 1977; Stabilized 17D yellow fever vaccine: dose response studies, clinical reactions and effects on hepatic function. Journal of Biological Standardization s:181–186
    [Google Scholar]
13. Johnson R. T. 1964a; The pathogenesis of herpes virus encephalitis: I. Virus pathways to the nervous system of suckling mice demonstrated by fluorescent antibody staining. Journal of Experimental Medicine 1x9:343–356
    [Google Scholar]
14. Johnson R. T. 1964b; The pathogenesis of herpes-simplex virus encephalitis: II. A cellular basis for the development of resistance with age. Journal of Experimental Medicine 120:359–374
    [Google Scholar]
15. Kantoch M. 1978; Markers and vaccines. Advances in Virus Research 22:259–325
    [Google Scholar]
16. Lehmann-Grube F. 1971; Lymphocytic choriomeningitis virus. Virology Monographs 10:50–54
    [Google Scholar]
17. Lloyd W., Penna H. A. 1933a; Studies on pathogenesis of neurotropic yellow fever virus in Macacus rhesus . American Journal of Tropical Medicine 13:1–45
    [Google Scholar]
18. Lloyd W., Penna H. A. 1933b; Yellow fever virus encephalomyelitis in South American monkeys. American Journal of Tropical Medicine 13:243–264
    [Google Scholar]
19. Lloyd W., Theiler M., Ricci N. 1936; Modification of virulence of yellow fever virus in cultivation in tissues in vitro . Transactions of the Royal Society of Tropical Medicine and Hygiene 29:481–529
    [Google Scholar]
20. Martin M. 1969; Analyse des populations virales obtenues par la méthode des plages avec la Souche Frangaise du virus amaril viscerotrope. Annales de TInstitut Pasteur 116:391–403
    [Google Scholar]
21. Mason R. A., Tauraso N. M., Spertzel R. O., Ginn R. K. 1973; Yellow fever vaccine: direct challenge of monkeys given graded doses of 17D vaccine. Applied Microbiology 25:539–544
    [Google Scholar]
22. Mathis E., Sellards A. J., Laigret J. 1928; Sensibility du macacus rhesus au virus de la fievre jaune. Compte rendu de I’Academie des sciences 186:604–606
    [Google Scholar]
23. Reed L. J., Muench H. 1938; A simple method of estimating fifty per cent end points. American Journal of Hygiene 27:493–497
    [Google Scholar]
24. Stevens J. G., Cook M. L. 1971; Restriction of herpes simplex virus by macrophages: an analysis of the cell-virus interaction. Journal of Experimental Medicine 133:19–38
    [Google Scholar]
25. Strode G. K. (editor) 1951 In Yellow Fever New York: McGraw-Hill;
    [Google Scholar]
26. Theiler M., Downs W. G. 1973 In The Arthropod-Borne Viruses of Vertebrates New Haven & London: Yale University Press;
    [Google Scholar]
27. Theiler M., Smith H. H. 1937; Use of yellow fever virus modified by in vitro cultivation for human immunization. Journal of Experimental Medicine 65:787–800
    [Google Scholar]
28. Walder R., Bradish C. J. 1975; Venezuelan equine encephalomyelitis virus (VEEV): strain differentiation and specification of virulence markers. Journal of General Virology 26:265–275
    [Google Scholar]
29. Walder R., Bradish C. J. 1979; Multi-factorial specification of virus-host interactions: studies with strains of Venezuelan equine encephalomyelitis virus in mice. Journal of General Virology 44:373–382
    [Google Scholar]